E-cadherin and α, β-, and γ-catenin protein expression in relation to metastasis in human breast carcinoma

Journal of Pathology

Volumn 185, Issue 3, 1998, Pages 262-266

  Bukholm, I K ^a   Nesland, J M ^a,b   Karesen R ^c   Jacobsen, U ^d   Borresen Dale A L ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d Buskerud Central Hospital   (Norway)

Author keywords

Breast carcinoma; E cadherin; Immunohistochemistry; Metastasis; catenin; catenin; catenin

Indexed keywords

ALPHA CATENIN; BETA CATENIN; UVOMORULIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031825010     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y     Document Type: Article

References (39)

1. Woods DF, Bryant PJ. Apical junctions and cell signalling in epithelia. J Cell Sci 1993; 17: 171-181.
2. Kirkpatrick CM, Pfeifer M. Cell-cell junctions as cellular signalling centers. Curr Opin Genet Dev 1995; 5: 56-65.
3. Tsukita S, Nagafuchi A. The undercoat of adherens junctions: a key specialized structure in organogenesis and carcinogenesis. Cell Struct Funct 1990; 15: 7-12.
4. Boller K, Vestweber D, Kemler R. Cell-adhesion molecule uvomorulin is localized in the intermediate junctions of adult intestinal epithelial cells. J Cell Biol 1985; 100: 327-332.
5. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-185.
6. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66: 107-119.
7. Chen WC, Obrink B. Cell-cell contacts mediated by E-cadherin (uvomorulin) restrict invasive behavior of L-cells. J Cell Biol 1991; 114: 319-327.
8. Pierceall WE, Woodard AS, Morrow JS, Rimm DL, Fearon ER. Frequent alterations in E-cadherin and alpha-and beta-catenin expression in human breast cancer cell lines. Oncogene 1995; 11: 1319-1326.
9. Vestweber D, Kemler R. Some structural and functional aspects of the cell adhesion molecule uvomorulin. Cell Differ 1984; 15: 269-273.
10. Nagafuchi A, Takeichi M, Tsukita S. The 102 kD cadherin-associated protein: similarity to vinculin and posttranscriptional regulation of expression. Cell 1991; 65: 849-857.
11. Herrenknecht K, Ozawa M, Eckerskorn C, Lottspeich F, Lenter M, Kemler R. The uvomorulin-anchorage protein alpha catenin is a vinculin homologue. Proc Natl Acad Sci USA 1991; 88: 9156-9160.
12. McCrea PD, Turck CW, Gumbiner B. A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. Science 1991; 254: 1359-1361.
13. Nagafuchi A, Takeichi M. Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J 1988; 7: 3679-3684.
14. Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 1989; 8: 1711-1717.
15. Huslsken J, Birchmeier W, Behrens J. E-cadherin and APC compete for the interaction with beta-catenin and cytoskeleton. J Cell Biol 1994; 127: 2061-2069.
16. Nagafuchi A, Takeichi M. Transmembrane control of cadherin mediated cell adhesion: a 94 kDa protein functionally associated with a specific region of the cytoplasmic domain of E-cadherin. Cell 1989; 1: 37-44.
17. Ozawa M, Kelmer R. Molecular organization of the uvomorulin-catenin complex. J Cell Biol 1992; 116: 989-996.
18. Miller JR, Moon RT. Signal transduction through beta catenin and specification of cell fate during embryogenesis. Genes Dev 1996; 10: 2527-2539.
19. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996; 7: 345-357.
20. Munemitsu S, Souza B, Muller O, Albert I, Rubinfeld B, Polakis P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 1994; 54: 3676-3681.
21. Mayer B, Johnson JP, Leitl F, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993; 53: 1690-1695.
22. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991; 51: 6328-6337.
23. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HF, Debruyne FM, Schalken JA. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 1993; 53: 3241-3245.
24. Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993; 142: 987-993.
25. Glukhova M, Koteliansky V, Sastre X, Thiery JP. Adhesion systems in normal breast and in invasive breast carcinoma. Am J Pathol 1995; 146: 706-716.
26. Bukholm I, Nesland JM, Kåresen R, Jacobsen U, Borresen-Dale AL. Relationship between abnormal p53 protein and down-regulation of E-cadherin in human breast carcinomas. J Pathol. (submitted).
27. Kadowaki T, Shiozaki H, Inoue M, et al. E-cadherin and alpha-catenin expression in human esophageal cancer. Cancer Res 1994; 54: 291-296.
28. Lipponen P, Saarelainen E, Ji H, Aaltomaa S, Syrjanen K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 1994; 174: 101-109.
29. Liotta LA, Kohn E. Cancer invasion and metastases (clinical conference). J Am Med Assoc 1990; 263: 1123-1126.
30. Sommers CL, Gelmann EP, Kemler R, Cowin P, Byers SW. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res 1994; 54: 3544-3552.
31. Kinch MS, Clark GJ, Der CJ, Burridge K. Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia. J Cell Biol 1995; 130: 461-471.
32. Bukholm I, Nesland JM, Kåresen R, Jacobsen U, Borresen AL. Relationship between abnormal p53 protein and failure to express p21. J Pathol 1997; 181: 140-145.
33. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
34. Rimm DL, Sinard JH, Morrow JS. Reduced alpha-catenin and E-cadherin expression in breast cancer. Lab Invest 1995; 72: 506-512.
35. Takayama T, Shiozaki H, Shibamoto S, et al. Beta-catenin expression in human cancers. Am J Pathol 1996; 148: 39-46.
36. Shiozaki H, Iihara K, Oka H, et al. Immunohistochemical detection of alpha-catenin expression in human cancers. Am J Pathol 1994; 144: 667-674.
37. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/ -colon carcinoma. Science 1997; 275: 1784-1787.
38. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signalling in colon cancer by mutation in beta-catenin or APC. Science 1997; 275: 1787-1790.
39. Rubinfeld B, Robins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 1997; 275: 1790-1792.